Study of a Live rNDV Based Vaccine Against COVID-19
NCT04871737
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
91
Enrollment
INDUSTRY
Sponsor class
Conditions
SARS-CoV-2 Infection
Interventions
BIOLOGICAL:
Recombinant NDV Vectored Vaccine for SARS-CoV-2
Sponsor
Laboratorio Avi-Mex, S.A. de C.V.
Collaborators
[object Object]
[object Object]